These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9826558)

  • 1. Affinities of different proteins and peptides for lipopolysaccharide as determined by biosensor technology.
    de Haas CJ; Haas PJ; van Kessel KP; van Strijp JA
    Biochem Biophys Res Commun; 1998 Nov; 252(2):492-6. PubMed ID: 9826558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human granulocytes express a 55-kDa lipopolysaccharide-binding protein on the cell surface that is identical to the bactericidal/permeability-increasing protein.
    Weersink AJ; van Kessel KP; van den Tol ME; van Strijp JA; Torensma R; Verhoef J; Elsbach P; Weiss J
    J Immunol; 1993 Jan; 150(1):253-63. PubMed ID: 7678030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A synthetic lipopolysaccharide-binding peptide based on amino acids 27-39 of serum amyloid P component inhibits lipopolysaccharide-induced responses in human blood.
    de Haas CJ; van der Tol ME; Van Kessel KP; Verhoef J; Van Strijp JA
    J Immunol; 1998 Oct; 161(7):3607-15. PubMed ID: 9759883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonistic effects of lipopolysaccharide binding protein and bactericidal/permeability-increasing protein on lipopolysaccharide-induced cytokine release by mononuclear phagocytes. Competition for binding to lipopolysaccharide.
    Dentener MA; Von Asmuth EJ; Francot GJ; Marra MN; Buurman WA
    J Immunol; 1993 Oct; 151(8):4258-65. PubMed ID: 8409400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interchangeable endotoxin-binding domains in proteins with opposite lipopolysaccharide-dependent activities.
    Schumann RR; Lamping N; Hoess A
    J Immunol; 1997 Dec; 159(11):5599-605. PubMed ID: 9548502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The BPI/LBP family of proteins: a structural analysis of conserved regions.
    Beamer LJ; Carroll SF; Eisenberg D
    Protein Sci; 1998 Apr; 7(4):906-14. PubMed ID: 9568897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein fusions of BPI with CETP retain functions inherent to each.
    Lloyd DB; Bonnette P; Thompson JF
    Biochemistry; 2006 Oct; 45(43):12954-9. PubMed ID: 17059212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A synthetic peptide derived from bactericidal/permeability-increasing protein neutralizes endotoxin in vitro and in vivo.
    Jiang Z; Hong Z; Guo W; Xiaoyun G; Gengfa L; Yongning L; Guangxia X
    Int Immunopharmacol; 2004 Apr; 4(4):527-37. PubMed ID: 15099530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between CD14 lipopolysaccharide binding protein and bactericidal/permeability-increasing protein during lipopolysaccharide-induced cell activation.
    Dentener MA; Von Asmuth EJ; Francot GJ; Buurman WA
    Prog Clin Biol Res; 1994; 388():59-70. PubMed ID: 7530372
    [No Abstract]   [Full Text] [Related]  

  • 10. Structural requirements for intracellular processing and sorting of bactericidal/permeability-increasing protein (BPI): comparison with lipopolysaccharide-binding protein.
    Bülow E; Gullberg U; Olsson I
    J Leukoc Biol; 2000 Nov; 68(5):669-78. PubMed ID: 11073106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant bactericidal/permeability-increasing protein inhibits endotoxin-induced high-mobility group box 1 protein gene expression in sepsis.
    Zhang LT; Yao YM; Lu JQ; Yan XJ; Yu Y; Sheng ZY
    Shock; 2008 Feb; 29(2):278-84. PubMed ID: 17693935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histones: a novel class of lipopolysaccharide-binding molecules.
    Augusto LA; Decottignies P; Synguelakis M; Nicaise M; Le Maréchal P; Chaby R
    Biochemistry; 2003 Apr; 42(13):3929-38. PubMed ID: 12667084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and expression analysis on bactericidal permeability-increasing protein (BPI)/lipopolysaccharide-binding protein (LBP) of ark shell, Scapharca broughtonii.
    Mao Y; Zhou C; Zhu L; Huang Y; Yan T; Fang J; Zhu W
    Fish Shellfish Immunol; 2013 Sep; 35(3):642-52. PubMed ID: 23742867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis.
    Chockalingam A; McKinney CE; Rinaldi M; Zarlenga DS; Bannerman DD
    Vet Microbiol; 2007 Nov; 125(1-2):80-90. PubMed ID: 17560054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of LPS-responses by synthetic peptides derived from LBP associates with the ability of the peptides to block LBP-LPS interaction.
    Araña Mde J; Vallespi MG; Chinea G; Vallespi GV; Rodriguez-Alonso I; Garay HE; Buurman WA; Reyes O
    J Endotoxin Res; 2003; 9(5):281-91. PubMed ID: 14577844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Competition between rBPI23, a recombinant fragment of bactericidal/permeability-increasing protein, and lipopolysaccharide (LPS)-binding protein for binding to LPS and gram-negative bacteria.
    Gazzano-Santoro H; Mészáros K; Birr C; Carroll SF; Theofan G; Horwitz AH; Lim E; Aberle S; Kasler H; Parent JB
    Infect Immun; 1994 Apr; 62(4):1185-91. PubMed ID: 8132325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of single amino acid residues essential for the binding of lipopolysaccharide (LPS) to LPS binding protein (LBP) residues 86-99 by using an Ala-scanning library.
    Reyes O; Vallespi MG; Garay HE; Cruz LJ; González LJ; Chinea G; Buurman W; Araña MJ
    J Pept Sci; 2002 Apr; 8(4):144-50. PubMed ID: 11991204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The genomic organization of the genes for human lipopolysaccharide binding protein (LBP) and bactericidal permeability increasing protein (BPI) is highly conserved.
    Hubacek JA; Büchler C; Aslanidis C; Schmitz G
    Biochem Biophys Res Commun; 1997 Jul; 236(2):427-30. PubMed ID: 9240454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of lipopolysaccharide-binding functions of CD14 and MD-2.
    Koraha J; Tsuneyoshi N; Kimoto M; Gauchat JF; Nakatake H; Fukudome K
    Clin Diagn Lab Immunol; 2005 Nov; 12(11):1292-7. PubMed ID: 16275943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening of mimetic peptides for CD14 binding site with LBP and antiendotoxin activity of mimetic peptide in vivo and in vitro.
    Xu Z; Qian GS; Li Q; Feng QJ; Wu GM; Li KL
    Inflamm Res; 2009 Jan; 58(1):45-53. PubMed ID: 19115038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.